US 11459320
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders
granted A61KA61K31/42A61K31/4402
Quick answer
US patent 11459320 (Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/42, A61K31/4402, A61K31/53, A61K31/541